Heimdall Insights

Global Infertility Drugs Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Infertility Drugs Market was valued at $4.2 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.1% CAGR, to an estimated market size of $5.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global infertility drugs market comprises pharmaceutical formulations designed to treat reproductive dysfunctions in both men and women. The scope includes gonadotropins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), and other hormonal therapies used to stimulate ovulation, regulate hormone levels, or improve sperm quality, particularly in conjunction with Assisted Reproductive Technology (ART) like IVF and IUI.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Infertility Drugs Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Gonadotropins
  • Aromatase Inhibitors
  • Other Drugs